Multiple myeloma is a cancer that develops in the plasma cells of white blood cells. Antibodies that detect and destroy germs are produced by healthy plasma cells, which aid in the battle against infections.
Cancerous plasma cells grow in the bone marrow and drive out healthy blood cells in multiple myeloma. Instead of producing beneficial antibodies, cancer cells create aberrant proteins that might cause problems.
Multiple myeloma treatment isn’t always required right away. Your doctor may prescribe diligent monitoring instead of early treatment if the multiple myeloma is slow developing and not causing signs and symptoms. There are a variety of treatment choices for patients with multiple myeloma who need help controlling the disease.
Dr. Neema Bhat
MBBS, MD (USA), FAAP (USA)
Hematology, BMT Physician, & Pediatric Oncology
Dr Neema Bhat graduated from Sri Devaraj Urs Medical College, Kolar with high honors and a Gold Medal in Physiology. She completed her Postgraduation from Cooper University Hospital, Camden, New Jersey, USA. Following which she pursued her Superspeciality Fellowship in Haematology/Oncology and Bone Marrow Transplantation from Penn State Health, Hershey, Pennsylvania, USA.
Areas of Special Interest: Blood and Marrow Transplantation (Autologous and Allogeneic), Adult and Paediatric Acute and Chronic Leukemias, Hodgkin’s and Non-Hodgkin’s Lymphomas, Aplastic Anemia, Thrombocytopenia, Autoimmune Hemolytic anemias, Bleeding disorders, Thromboses and prothrombotic conditions, Hemoglobinopathies, congenital anemias, immunodeficiencies, Paediatric Brain tumors, bone tumors, Wilm’s tumors.
#multiplemyeloma #myeloma #bloodcancer #drneemabhat #multiplemyelomaawareness #cancer #myelomaawareness #bonemarrowtransplant #lymphoma #leukemia #multiplemyelomacancer